Shire Sues Apotex, Nostrum Over Carbatrol ANDAs

Law360, New York (July 7, 2008, 12:00 AM EDT) -- Drugmaker Shire LLC has sued generics makers Apotex Inc. and Nostrum Pharmaceuticals Inc. to stop them from making a generic version of Shire's popular epilepsy drug Carbatrol.

On Wednesday, Shire filed a complaint against Apotex in the U.S. District Court for the Eastern District of Texas and a separate complaint against Nostrum in the U.S. District Court for the District of New Jersey.

Apotex and Nostrum each sent Shire a letter in May saying that they had filed an abbreviated new drug application with the U.S....
To view the full article, register now.